Facilitating Access to Approved Medication

Mosunetuzumab-AXGB Concentrate For Solution For Infusion
Mosunetuzumab is indicated for the treatment of adults with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.

Get Access To Mosunetuzumab-AXGB Concentrate For Solution For Infusion

Ribociclib-tablets Available Price In India UK Saudi Arabia

Mosunetuzumab-AXGB Concentrate For Solution For Infusion

  • API: Idelalisib
  • Packaging: Tablets
  • Strength: 100 mg and 150 mg Tablets

What is Mosunetuzumab-AXGB Concentrate For Solution For Infusion used for?

Idelalisib is a kinase inhibitor indicated for the treatment of patients with:

Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities.

Note: (For Prescribing Information Approved Drugs, see)

  • The Food and Drug Administration (FDA), USA.
  • The European Medicines Agency (EMA).
    Disclaimer

    All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Mosunetuzumab-AXGB Concentrate For Solution For Infusion is a pharmaceutical drug  To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.